Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davide Chiasserini

Showing results (61-70 of 88) with videos related to

Pageof 9
Sort By:
Alzheimer'S Research & Therapy|July 29, 2017
Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer's disease core biomarkers in Lewy body disorders and Alzheimer's dementiaDavide Chiasserini, Leonardo Biscetti, Paolo Eusebi, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 23, 2016
Longitudinal changes in CSF alpha-synuclein species reflect Parkinson's disease progressionNour K Majbour, Nishant N Vaikath, Paolo Eusebi, et al.
Journal of Alzheimer'S Disease : JAD|April 23, 2016
Validation of microRNAs in Cerebrospinal Fluid as Biomarkers for Different Forms of Dementia in a Multicenter StudyMareike Müller, H Bea Kuiperij, Alexandra A M Versleijen, et al.
Plos One|July 2, 2014
Factors influencing the measurement of lysosomal enzymes activity in human cerebrospinal fluidEmanuele Persichetti, Davide Chiasserini, Lucilla Parnetti, et al.
British Journal of Cancer|February 22, 2023
Quantitative SWATH-based proteomic profiling of urine for the identification of endometrial cancer biomarkers in symptomatic womenKelechi Njoku, Andrew Pierce, Bethany Geary, et al.
Scientific Reports|February 19, 2016
Persistent activation of microglia and NADPH oxidase [corrected] drive hippocampal dysfunction in experimental multiple sclerosisMassimiliano Di Filippo, Antonio de Iure, Carmela Giampà, et al.
Molecular Neurobiology|June 28, 2018
Characterization of Brain Lysosomal Activities in GBA-Related and Sporadic Parkinson's Disease and Dementia with Lewy BodiesTim E Moors, Silvia Paciotti, Angela Ingrassia, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 7, 2024
Fully automated measurement of plasma Aβ42/40 and p-tau181: Analytical robustness and concordance with cerebrospinal fluid profile along the Alzheimer's disease continuum in two independent cohortsGiovanni Bellomo, Sherif Bayoumy, Alfredo Megaro, et al.
Bioinformatics (Oxford, England)|December 3, 2019
The use of missing values in proteomic data-independent acquisition mass spectrometry to enable disease activity discriminationKathryn A McGurk, Arianna Dagliati, Davide Chiasserini, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 7, 2011
Cerebrospinal fluid Tau/α-synuclein ratio in Parkinson's disease and degenerative dementiasLucilla Parnetti, Davide Chiasserini, Gianni Bellomo, et al.
Pageof 9

Showing results (61-70 of 88) with videos related to

Sort By:
Pageof 9
Alzheimer'S Research & Therapy|July 29, 2017
Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer's disease core biomarkers in Lewy body disorders and Alzheimer's dementiaDavide Chiasserini, Leonardo Biscetti, Paolo Eusebi, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 23, 2016
Longitudinal changes in CSF alpha-synuclein species reflect Parkinson's disease progressionNour K Majbour, Nishant N Vaikath, Paolo Eusebi, et al.
Journal of Alzheimer'S Disease : JAD|April 23, 2016
Validation of microRNAs in Cerebrospinal Fluid as Biomarkers for Different Forms of Dementia in a Multicenter StudyMareike Müller, H Bea Kuiperij, Alexandra A M Versleijen, et al.
Plos One|July 2, 2014
Factors influencing the measurement of lysosomal enzymes activity in human cerebrospinal fluidEmanuele Persichetti, Davide Chiasserini, Lucilla Parnetti, et al.
British Journal of Cancer|February 22, 2023
Quantitative SWATH-based proteomic profiling of urine for the identification of endometrial cancer biomarkers in symptomatic womenKelechi Njoku, Andrew Pierce, Bethany Geary, et al.
Scientific Reports|February 19, 2016
Persistent activation of microglia and NADPH oxidase [corrected] drive hippocampal dysfunction in experimental multiple sclerosisMassimiliano Di Filippo, Antonio de Iure, Carmela Giampà, et al.
Molecular Neurobiology|June 28, 2018
Characterization of Brain Lysosomal Activities in GBA-Related and Sporadic Parkinson's Disease and Dementia with Lewy BodiesTim E Moors, Silvia Paciotti, Angela Ingrassia, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 7, 2024
Fully automated measurement of plasma Aβ42/40 and p-tau181: Analytical robustness and concordance with cerebrospinal fluid profile along the Alzheimer's disease continuum in two independent cohortsGiovanni Bellomo, Sherif Bayoumy, Alfredo Megaro, et al.
Bioinformatics (Oxford, England)|December 3, 2019
The use of missing values in proteomic data-independent acquisition mass spectrometry to enable disease activity discriminationKathryn A McGurk, Arianna Dagliati, Davide Chiasserini, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 7, 2011
Cerebrospinal fluid Tau/α-synuclein ratio in Parkinson's disease and degenerative dementiasLucilla Parnetti, Davide Chiasserini, Gianni Bellomo, et al.
Pageof 9